Olshan Frome Wolosky represented Velan Capital in the transaction. Velan Capital co-led an investment in a $12 million PIPE consisting of Series B preferred stock and...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky represented ImmunityBio in the transaction. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, has entered into a definitive agreement to acquire a leasehold interest in 409,000...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky and Simpson Thacher & Bartlett represented Kaufman Astoria Studios in the transaction. The joint venture of Hackman Capital Partners and Square Mile Capital...
You must be a Standard 1 Year member to access this content.
